Many digital health companies struggle to achieve commercial traction, despite having very “cool” technology. And as a result, they find it difficult to meet the expectations of their shareholders achieve revenue growth.
This breakfast briefing discusses the need to have an integrated commercial and regulatory strategy in order to be successful with market access, and how this can link to the “equity story” to investors.
A particular focus is the opportunity to use the pharmaceutical industry as an “early adopter” of technology, and the challenge of selling to and delivering to this market.
SIGN IN !
Registration until Thursday, February 11th, 2019
ABOUT THE SPEAKER
Derek Hill is President of Panoramic Digital Health SASU, a Grenoble based start up. He also has an academic appointment as Full Professor and Director of Enterprise at UCL in London. He previously founded IXICO, in 2004, to provide digital technology and services to the pharmaceutical industry, to support both drug development and management of patients. IXICO was initially focused on medical imaging (MRI, PET, CT etc) but expanded into other digital technologies including wearable biosensors. Under Derek’s leadership, IXICO reached profitability in 2011 and was admitted onto the London Stock Exchange AIM in 2013. Following the acquisition of optimal medicine in 2015, Derek stepped down as CEO and founded a new business, Panoramic Digital Health in 2018, focused on technology to support regulatory compliance of digital health technologies. He also works with a number of customers in the pharmaceutical and medtech sectors on their regulatory and commercial strategy.
Derek did an undergraduate degree in Physics at Imperial College, MSc in Medical Physics, PhD in medical image analysis, and then held academic positions in KCL and UCL. He took business training at the London Business School as part of UCL’s CSEL programme. In addition to his business activities, he is a member of the Executive Committee of the Dementias Platform UK, was a member of Prime Minister David Cameron’s Research Advisory Group for Dementia, has been a regular commentator on science news stories in the media.
04 76 54 95 63
MEDICALPS members: free (1 person/structure)
Non – members fees: 60 € (payment by cheque or bank transfer)